Who
Samuel C. Scott III
Director
Company insider
Files Form 4 as: Director, GCM Grosvenor; Director, The Bank of New York Mellon; Director, Abbott Laboratories; Director, Motorola Solutions; Chairman, President and CEO, Ingredion; Director, Bank Of New York Co.
In numbers
- Trades disclosed
- 333
- Buys
- 1
- Sells
- 10
- Bought
- $338K
- Sold
- $12.5M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 30 Dec 2005
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $74K5,722 at $12.89 | filing |
| 30 Jun 2026filed 1 Jul 2026 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $74K5,996 at $12.30 | filing |
| 30 Jun 2026filed 1 Jul 2026 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $74K5,996 at $12.30 | filing |
| 31 Mar 2026filed 2 Apr 2026 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $74K7,526 at $9.80 | filing |
| 31 Mar 2026filed 2 Apr 2026 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $74K7,526 at $9.80 | filing |
| 31 Dec 2025filed 2 Jan 2026 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $74K6,516 at $11.32 | filing |
| 31 Dec 2025filed 2 Jan 2026 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $74K6,516 at $11.32 | filing |
| 30 Sep 2025filed 1 Oct 2025 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $74K6,111 at $12.07 | filing |
| 30 Jun 2025filed 1 Jul 2025 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $74K6,380 at $11.56 | filing |
| 31 Mar 2025filed 1 Apr 2025 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $59K4,441 at $13.23 | filing |
| 31 Dec 2024filed 2 Jan 2025 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $59K4,789 at $12.27 | filing |
| 30 Sep 2024filed 1 Oct 2024 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $59K5,190 at $11.32 | filing |
| 28 Jun 2024filed 2 Jul 2024 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $59K6,020 at $9.76 | filing |
| 28 Mar 2024filed 1 Apr 2024 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $59K6,082 at $9.66 | filing |
| 29 Dec 2023filed 2 Jan 2024 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $59K6,557 at $8.96 | filing |
| 29 Sep 2023filed 3 Oct 2023 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $59K7,571 at $7.76 | filing |
| 30 Jun 2023filed 3 Jul 2023 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $59K7,792 at $7.54 | filing |
| 31 Mar 2023filed 4 Apr 2023 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $59K7,523 at $7.81 | filing |
| 30 Dec 2022filed 3 Jan 2023 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $50K6,571 at $7.61 | filing |
| 30 Sep 2022filed 3 Oct 2022 | GCMG GCM Grosvenoroption or derivative · Capital Markets & Asset Management | SEC FORM 4 Code A | $50K6,338 at $7.89 | filing |
News
Motorola Solutions, Inc. $MSI Stake Lifted by Crossmark Global Holdings Inc.MSI · dailypolitical.com · 22 Oct 2026Abbott Laboratories announces a baby formula spinoff companyABT · marketplace.org · 21 Oct 2026Abbott anticipates nutrition separation by end of next year and forecasts Q4 adjusted EPS of $1.62-$1.67 (NYSE:ABT)ABT · seekingalpha.com · 21 Oct 2026Abbott Laboratories plans to spin off nutrition businessABT · chicagotribune.com · 21 Oct 2026Columbus Macro LLC Sells 2,176 Shares of Motorola Solutions, Inc. $MSIMSI · dailypolitical.com · 15 Oct 2026A Day of Hope: Motorola Solutions Volunteers Transform AlexMSI · 3blmedia.com · 14 Oct 2026
0 headlines in the last 90 days name Samuel C. Scott III; 6 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.